Quetiapine Accord
On the Bulgarian pack: Кветиапин Акорд 400 mg таблетки с удължено освобождаване
400 mg prolonged - release tablets · prolonged release tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Quetiapine
- Made by
- Accord Healthcare Polska Sp. z.o.o.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (quetiapine fumarate). It describes the substance, not this Bulgarian product — its uses and doses can differ.
The mechanism of action of quetiapine in the listed indications is unclear.
However, the efficacy of quetiapine in these indications could be mediated through a combination of dopamine type 2 (D 2 ) and serotonin type 2 (5HT 2 ) antagonism.
Quetiapine is unlikely to interfere with the metabolism of drugs metabolized by cytochrome P450 enzymes.
The bioavailability of quetiapine is marginally affected by administration with food, with C max and AUC values increased by 25% and 15%, respectively.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-16
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (quetiapine fumarate). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS; and SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning.
- Known hypersensitivity to quetiapine or any components in the formulation.
- ( 4 ) Hypersensitivity to quetiapine or to any excipients in the quetiapine tablets formulation.
- Anaphylactic reactions have been reported in patients treated with quetiapine tablets.
Most common adverse reactions (incidence ≥5% and twice placebo): Adults: somnolence, dry mouth, dizziness, constipation, asthenia, abdominal pain, postural hypotension, pharyngitis, weight gain, lethargy, ALT increased, dyspepsia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States53 matching products
- Quetiapine Fumarate 400 mg · Tablet29 makers
- Quetiapine 400 mg · Tablet, Film Coated16 makers
- Quetiapine Extended Release 400 mg · Tablet, Film Coated, Extended Release3 makers
- Seroquel 400 mg · Tablet, Film Coated2 makers
- Seroquel Xr 400 mg · Tablet, Extended Release2 makers
- Quetiapine Fumarate Er 400 mg · Tablet, Extended Release
Spain30 matching products
- QUETIAPINA NORMON 400 mg · comprimido de liberación prolongada2 makers
- QUETIAPINA QUALIGEN 400 mg · comprimido de liberación prolongada2 makers
- SEROQUEL PROLONG 400 mg · comprimido de liberación prolongada2 makers
- PSICOTRIC 400 mg · comprimido recubierto con película
- PSICOTRIC PROLONG 400 mg · comprimido de liberación prolongada
- QUDIX PROLONG 400 mg · comprimido de liberación prolongada
- QUETIAPINA ALTER 400 mg · comprimido de liberación prolongada
- QUETIAPINA AUROVITAS PHARMA 400 mg · comprimido de liberación prolongada
Canada15 matching products
- QUETIAPINE XR 400 mg · tablet (extended-release)3 makers
- ACH-QUETIAPINE FUMARATE XR 400 mg · tablet (extended-release)
- AG-QUETIAPINE XR 400 mg · tablet (extended-release)
- APO-QUETIAPINE XR 400 mg · tablet (extended-release)
- BIO-QUETIAPINE XR 400 mg · tablet (extended-release)
- MINT-QUETIAPINE XR 400 mg · tablet (extended-release)
- NB-QUETIAPINE XR 400 mg · tablet (extended-release)
- NRA-QUETIAPINE XR 400 mg · tablet (extended-release)
Netherlands10 matching products
- Quetiapine Accord 400 mg 400 mg · tablet met verlengde afgifte
- Quetiapine Accord 400 mg filmomhulde tabletten 400 mg · filmomhulde tablet
- Quetiapine Aurobindo 400 mg 400 mg · tablet met verlengde afgifte
- Quetiapine Edest 400 mg tabletten met verlengde afgifte 400 mg · tablet met verlengde afgifte
- Quetiapine Fairmed Healthcare 400 mg tabletten met verlengde afgifte 400 mg · tablet met verlengde afgifte
- Quetiapine Retard 400 mg Teva 400 mg · tablet met verlengde afgifte
- Quetiapine Retard Viatris 400 mg 400 mg · tablet met verlengde afgifte
- Quetiapine Sandoz SR 400 mg 400 mg · tablet met verlengde afgifte
SwitzerlandNo exact match for this strength and form
Details
| Made by | Accord Healthcare Polska Sp. z.o.o. · Poland |
|---|---|
| Active substance | Quetiapine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 400 mg prolonged - release tablets |
| Form | prolonged release tablet |
| Pack sizes | 10 · 30 · 50 · 60 · 100 |
| Classification | N05AH04 · Pain, sleep, mood, epilepsy and the brain |
| Name in the register | Кветиапин Акорд 400 mg таблетки с удължено освобождаване |
| Reg. no. | 20110512 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
9 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- film coated tablet3 products
- prolonged release tablet2 products
- 300 mg prolonged - release tablets
- 400 mg prolonged - release tablets
- film - coated tablets2 products
- prolonged - release tablets2 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.